Grant Advances HIV Gene Therapy Research
The Campbell Foundation funded the project because it tackles a major barrier to durable HIV therapies.
All Posts by
The Campbell Foundation funded the project because it tackles a major barrier to durable HIV therapies.
What scientists thought they knew about an important TB enzyme is wrong. "It acts in a completely different way," says Luiz Pedro Carvalho, Ph.D. His research appears in the journal PNAS.
AI can help us search enormous numbers of chemical structures. But it cannot look at a patient waiting for a medicine and decide which problem is worth a life's work.
A new screening approach developed in the lab of William Ja, Ph.D. is offering a new way to study the biology of aging.
The annual Kenan Fellows Summer Symposium gave students an opportunity to share their research and reflect on their experiences. See the photo gallery.
A new approach to "molecular glue" drug design snags an "undruggable" diabetes target.
Federal grants worth up to $7.4 million will boost research on treatments for mosquito-borne viral diseases.
A first-of-its-kind anti-cancer compound from the Chapman lab targets a heat shock protein found in some lung cancers.
Fourteen top local high school students have been selected to spend the summer researching in institute labs through the Kenan Internship program.
A proof-of-concept study suggests a monoclonal antibody could offer much-needed treatment for ARDS.